Clinical Trial Update: GOS and the Management of Hyperuricemia [NA]

View source ↗

Summary

An ongoing Sun Yat-sen University clinical trial is evaluating galacto-oligosaccharides (GOS) for managing hyperuricemia; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperuricemia

Drugs mentioned

• GOS (galacto-oligosaccharide)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Subjects With Hyperuricemia | NA | Status: RECRUITING